258 related articles for article (PubMed ID: 25480793)
1. Molecular basis of the dominant negative effect of a glycine transporter 2 mutation associated with hyperekplexia.
Arribas-González E; de Juan-Sanz J; Aragón C; López-Corcuera B
J Biol Chem; 2015 Jan; 290(4):2150-65. PubMed ID: 25480793
[TBL] [Abstract][Full Text] [Related]
2. Rescue of two trafficking-defective variants of the neuronal glycine transporter GlyT2 associated to hyperekplexia.
de la Rocha-Muñoz A; Melgarejo E; Aragón C; López-Corcuera B
Neuropharmacology; 2021 May; 189():108543. PubMed ID: 33794243
[TBL] [Abstract][Full Text] [Related]
3. Hyperekplexia-associated mutations in the neuronal glycine transporter 2.
López-Corcuera B; Arribas-González E; Aragón C
Neurochem Int; 2019 Feb; 123():95-100. PubMed ID: 29859229
[TBL] [Abstract][Full Text] [Related]
4. Calnexin-assisted biogenesis of the neuronal glycine transporter 2 (GlyT2).
Arribas-González E; Alonso-Torres P; Aragón C; López-Corcuera B
PLoS One; 2013; 8(5):e63230. PubMed ID: 23650557
[TBL] [Abstract][Full Text] [Related]
5. A novel dominant hyperekplexia mutation Y705C alters trafficking and biochemical properties of the presynaptic glycine transporter GlyT2.
Giménez C; Pérez-Siles G; Martínez-Villarreal J; Arribas-González E; Jiménez E; Núñez E; de Juan-Sanz J; Fernández-Sánchez E; García-Tardón N; Ibáñez I; Romanelli V; Nevado J; James VM; Topf M; Chung SK; Thomas RH; Desviat LR; Aragón C; Zafra F; Rees MI; Lapunzina P; Harvey RJ; López-Corcuera B
J Biol Chem; 2012 Aug; 287(34):28986-9002. PubMed ID: 22753417
[TBL] [Abstract][Full Text] [Related]
6. E3 ubiquitin ligases LNX1 and LNX2 are major regulators of the presynaptic glycine transporter GlyT2.
de la Rocha-Muñoz A; Núñez E; Arribas-González E; López-Corcuera B; Aragón C; de Juan-Sanz J
Sci Rep; 2019 Oct; 9(1):14944. PubMed ID: 31628376
[TBL] [Abstract][Full Text] [Related]
7. Endocytosis of the neuronal glycine transporter GLYT2: role of membrane rafts and protein kinase C-dependent ubiquitination.
de Juan-Sanz J; Zafra F; López-Corcuera B; Aragón C
Traffic; 2011 Dec; 12(12):1850-67. PubMed ID: 21910806
[TBL] [Abstract][Full Text] [Related]
8. Constitutive endocytosis and turnover of the neuronal glycine transporter GlyT2 is dependent on ubiquitination of a C-terminal lysine cluster.
de Juan-Sanz J; Núñez E; López-Corcuera B; Aragón C
PLoS One; 2013; 8(3):e58863. PubMed ID: 23484054
[TBL] [Abstract][Full Text] [Related]
9. The P429L loss of function mutation of the human glycine transporter 2 associated with hyperekplexia.
Kitzenmaier A; Schaefer N; Kasaragod VB; Polster T; Hantschmann R; Schindelin H; Villmann C
Eur J Neurosci; 2019 Dec; 50(12):3906-3920. PubMed ID: 31370103
[TBL] [Abstract][Full Text] [Related]
10. [Molecular bases of hereditary hyperekplexia].
Giménez C; Zafra F; López-Corcuera B; Aragón C
Rev Neurol; 2008 Dec 16-31; 47(12):648-52. PubMed ID: 19085882
[TBL] [Abstract][Full Text] [Related]
11. Na+/K+-ATPase is a new interacting partner for the neuronal glycine transporter GlyT2 that downregulates its expression in vitro and in vivo.
de Juan-Sanz J; Núñez E; Villarejo-López L; Pérez-Hernández D; Rodriguez-Fraticelli AE; López-Corcuera B; Vázquez J; Aragón C
J Neurosci; 2013 Aug; 33(35):14269-81. PubMed ID: 23986260
[TBL] [Abstract][Full Text] [Related]
12. P2X receptors up-regulate the cell-surface expression of the neuronal glycine transporter GlyT2.
Villarejo-López L; Jiménez E; Bartolomé-Martín D; Zafra F; Lapunzina P; Aragón C; López-Corcuera B
Neuropharmacology; 2017 Oct; 125():99-116. PubMed ID: 28734869
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease.
Carta E; Chung SK; James VM; Robinson A; Gill JL; Remy N; Vanbellinghen JF; Drew CJ; Cagdas S; Cameron D; Cowan FM; Del Toro M; Graham GE; Manzur AY; Masri A; Rivera S; Scalais E; Shiang R; Sinclair K; Stuart CA; Tijssen MA; Wise G; Zuberi SM; Harvey K; Pearce BR; Topf M; Thomas RH; Supplisson S; Rees MI; Harvey RJ
J Biol Chem; 2012 Aug; 287(34):28975-85. PubMed ID: 22700964
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease.
Rees MI; Harvey K; Pearce BR; Chung SK; Duguid IC; Thomas P; Beatty S; Graham GE; Armstrong L; Shiang R; Abbott KJ; Zuberi SM; Stephenson JB; Owen MJ; Tijssen MA; van den Maagdenberg AM; Smart TG; Supplisson S; Harvey RJ
Nat Genet; 2006 Jul; 38(7):801-6. PubMed ID: 16751771
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of endoplasmic-reticulum export of glycine transporter-1 (GLYT1).
Fernández-Sánchez E; Díez-Guerra FJ; Cubelos B; Giménez C; Zafra F
Biochem J; 2008 Feb; 409(3):669-81. PubMed ID: 17919119
[TBL] [Abstract][Full Text] [Related]
16. Presynaptic control of glycine transporter 2 (GlyT2) by physical and functional association with plasma membrane Ca2+-ATPase (PMCA) and Na+-Ca2+ exchanger (NCX).
de Juan-Sanz J; Núñez E; Zafra F; Berrocal M; Corbacho I; Ibáñez I; Arribas-González E; Marcos D; López-Corcuera B; Mata AM; Aragón C
J Biol Chem; 2014 Dec; 289(49):34308-24. PubMed ID: 25315779
[TBL] [Abstract][Full Text] [Related]
17. The presynaptic glycine transporter GlyT2 is regulated by the Hedgehog pathway in vitro and in vivo.
de la Rocha-Muñoz A; Núñez E; Vishwanath AA; Gómez-López S; Dhanasobhon D; Rebola N; López-Corcuera B; de Juan-Sanz J; Aragón C
Commun Biol; 2021 Oct; 4(1):1197. PubMed ID: 34663888
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of glycine transporter GlyT2 mutations in startle disease.
James VM; Gill JL; Topf M; Harvey RJ
Biol Chem; 2012 Apr; 393(4):283-9. PubMed ID: 22114948
[TBL] [Abstract][Full Text] [Related]
19. Glycine transporters GlyT1 and GlyT2 are differentially modulated by glycogen synthase kinase 3β.
Jiménez E; Núñez E; Ibáñez I; Zafra F; Aragón C; Giménez C
Neuropharmacology; 2015 Feb; 89():245-54. PubMed ID: 25301276
[TBL] [Abstract][Full Text] [Related]
20. The glycine transporter GlyT2 controls the dynamics of synaptic vesicle refilling in inhibitory spinal cord neurons.
Rousseau F; Aubrey KR; Supplisson S
J Neurosci; 2008 Sep; 28(39):9755-68. PubMed ID: 18815261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]